Marta Catálfamo

9.9k total citations · 2 hit papers
55 papers, 6.0k citations indexed

About

Marta Catálfamo is a scholar working on Immunology, Virology and Oncology. According to data from OpenAlex, Marta Catálfamo has authored 55 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 16 papers in Virology and 9 papers in Oncology. Recurrent topics in Marta Catálfamo's work include Immune Cell Function and Interaction (26 papers), T-cell and B-cell Immunology (24 papers) and HIV Research and Treatment (16 papers). Marta Catálfamo is often cited by papers focused on Immune Cell Function and Interaction (26 papers), T-cell and B-cell Immunology (24 papers) and HIV Research and Treatment (16 papers). Marta Catálfamo collaborates with scholars based in United States, Spain and Israel. Marta Catálfamo's co-authors include Jung‐Hyun Park, Pierre A. Henkart, Lionel Feigenbaum, Amala Alag, Alfred Singer, Batu Erman, Stanley Adoro, Terry I. Guinter, Masato Kubo and Philip J. Lucas and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Marta Catálfamo

54 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells

2010 2.9k citations Jung‐Hyun Park, Stanley Adoro et al. Nature Immunology profile →
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk

2014 567 citations Katrin D. Mayer-Barber, Bruno B. Andrade et al. Nature profile →

Peers

Countries citing papers authored by Marta Catálfamo

Since Specialization

Citations

This map shows the geographic impact of Marta Catálfamo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Catálfamo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Catálfamo more than expected).

Fields of papers citing papers by Marta Catálfamo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Catálfamo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Catálfamo. The network helps show where Marta Catálfamo may publish in the future.

Co-authorship network of co-authors of Marta Catálfamo

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Catálfamo. A scholar is included among the top collaborators of Marta Catálfamo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Catálfamo. Marta Catálfamo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	IL-27 effects on HIVGag-specific CD4 and CD8 T cell function 2025 ·Frontiers in Virology ·(unknown), (unknown), Jie Cheng, C. Christina Mehta, (unknown), Danish Mahmood, Princy Kumar, Marta Catálfamo	0
2	IL-27 expression regulation and its effects on adaptive immunity against viruses 2024 ·Frontiers in Immunology ·(unknown), (unknown), Marta Catálfamo	8
3	Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance 2021 ·Cancer Immunology Research ·(unknown), Zoe X. Malchiodi, Allison A. Fitzgerald, (unknown), Shangzi Wang, (unknown), Connor J. Cooper, Yue Shen, (unknown), Jerry M. Parks, Jeremy C. Smith, Marta Catálfamo, Elana J. Fertig, Sandra A. Jablonski, Louis M. Weiner	14
4	The role of protease-activated receptor 1 signaling in CD8 T cell effector functions 2021 ·iScience ·Hui Chen, Mindy Smith, Jasmin Herz, Tong Li, (unknown), Cécile Le Saout, (unknown), Jie Cheng, (unknown), José A. Martina, Pablo M. Irusta, Tatiana Karpova, Dorian B. McGavern, Marta Catálfamo	12
5	IL-7–dependent STAT1 activation limits homeostatic CD4+ T cell expansion 2017 ·JCI Insight ·Cécile Le Saout, Megan A. Luckey, Alejandro V. Villarino, Mindy Smith, (unknown), Timothy G. Myers, Hiromi Imamichi, Jung‐Hyun Park, John J. O’Shea, H. Clifford Lane, Marta Catálfamo	19
6	Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients 2016 ·AIDS ·(unknown), (unknown), (unknown), Cécile Le Saout, Stefania Pittaluga, Hui Chen, (unknown), Jeffrey D. Lifson, (unknown), Jing Qin, Michael C. Sneller, (unknown), Helen Sabzevari, H. Clifford Lane, Marta Catálfamo	24
7	Immunology careers at the NIH, FDA and CDC: different paths that focus on advancing public health 2015 ·Nature Immunology ·Marta Catálfamo, Alison C. Mawle, Daniela Verthelyi	1
8	Activated platelet–T-cell conjugates in peripheral blood of patients with HIV infection 2015 ·AIDS ·(unknown), Mindy Smith, (unknown), David Stephany, Adam Harned, Kunio Nagashima, (unknown), Stefania Pittaluga, Tomozumi Imamichi, Jing Qin, Adam Rupert, (unknown), H. Clifford Lane, Marta Catálfamo	41
9	Chronic Exposure to Type-I IFN under Lymphopenic Conditions Alters CD4 T Cell Homeostasis 2014 ·PLoS Pathogens ·Cécile Le Saout, (unknown), Hiromi Imamichi, (unknown), Zonghui Hu, Megan A. Luckey, Jung‐Hyun Park, Scott K. Durum, Mindy Smith, Adam Rupert, Michael C. Sneller, H. Clifford Lane, Marta Catálfamo	24
10	Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk breakdown → 2014 ·Nature ·Katrin D. Mayer-Barber, Bruno B. Andrade, Sandra D. Oland, Eduardo P. Amaral, Daniel L. Barber, Jacqueline Gonzales, Steven C. Derrick, Ruiru Shi, Nathella Pavan Kumar, (unknown), Xing Yuan, Guolong Zhang, Ying Cai, Subash Babu, Marta Catálfamo, Andres Μ. Salazar, Laura E. Via, Clifton E. Barry, Alan Sher	567
11	Imaging of lytic granule exocytosis in CD8+ cytotoxic T lymphocytes reveals a modified form of full fusion 2011 ·Cellular Immunology ·José A. Martina, Xufeng Wu, Marta Catálfamo, Takeshi Sakamoto, Chang Yi, John A. Hammer	15
12	Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells breakdown → 2010 ·Nature Immunology ·Jung‐Hyun Park, Stanley Adoro, Terry I. Guinter, Batu Erman, Amala Alag, Marta Catálfamo, Motoko Y. Kimura, Yongzhi Cui, Philip J. Lucas, Ronald E. Gress, Masato Kubo, Lothar Hennighausen, Lionel Feigenbaum, Alfred Singer	2928
13	Regulatory CD56 ^bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis 2006 ·Proceedings of the National Academy of Sciences ·Bibiana Bielekova, Marta Catálfamo, (unknown), Nicolle H. Packer, (unknown), Thomas A. Waldmann, Henry F. McFarland, Pierre A. Henkart, Roland Martinꝉ	465
14	CD1a and CD1c Activate Intrathyroidal T Cells during Graves’ Disease and Hashimoto’s Thyroiditis 2005 ·The Journal of Immunology ·Carme Roura‐Mir, Marta Catálfamo, Tan‐Yun Cheng, Ellen Marqusee, Gurdyal S. Besra, Dolores Jaraquemada, D. Branch Moody	41
15	Amplification of the lytic potential of effector/memory CD8+ cells by vector-based enhancement of ICAM-1 (CD54) in target cells: implications for intratumoral vaccine therapy 2004 ·Cancer Gene Therapy ·(unknown), Marta Catálfamo, Chie Kudo‐Saito, James W. Hodge, Jeffrey Schlom, Helen Sabzevari	33
16	IL‐15 Is a Growth Factor and an Activator of CD8 Memory T Cells 2002 ·Annals of the New York Academy of Sciences ·Nan‐ping Weng, Kebin Liu, Marta Catálfamo, Yu Li, Pierre A. Henkart	67
17	HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules 1999 ·International Immunology ·Marta Catálfamo, Laurence Serradell, Carme Roura‐Mir, (unknown), Mireia Sospedra, Marta Vives‐Pi, (unknown), Ricardo Pujol‐Borrell, (unknown)	16
18	HLA‐DM can partially replace the invariant chain for HLA‐DR transport and surface expression in transfected endocrine epithelial cells 1999 ·Tissue Antigens ·Laurence Serradell, Aura Muntasell, Marta Catálfamo, Mercè Martı́, Mauro W. Costa, C. de Préval, Dolores Jaraquemada	8
19	HLA‐DPp residue 69 plays a crucial role in allorecognition 1998 ·Tissue Antigens ·(unknown), Marta Catálfamo, Mayte Coiras, Alberto Álvarez, Dolores Jaraquemada, César Nombela, Miguel Sánchez‐Pérez, Javier Arroyo	21
20	Single‐cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's and Graves' disease 1997 ·European Journal of Immunology ·Carme Roura‐Mir, Marta Catálfamo, Mireia Sospedra, Laura Alcalde, Ricardo Pujol‐Borrell, Dolores Jaraquemada	102

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact